Rights and permissions
About this article
Cite this article
Bevacizumab an improvement on standard therapy in colorectal cancer. Inpharma Wkly. 1399, 7–8 (2003). https://doi.org/10.2165/00128413-200313990-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313990-00016